Osaic Holdings’s SAB Biotherapeutics SABS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.4K | Sell |
4,847
-100
| -2% | -$379 | ﹤0.01% | 5399 |
|
|
2025
Q1 | $6.73K | Sell |
4,947
-100
| -2% | -$136 | ﹤0.01% | 5940 |
|
|
2024
Q4 | $19.1K | Buy |
5,047
+513
| +11% | +$1.94K | ﹤0.01% | 5344 |
|
|
2024
Q3 | $12.2K | Hold |
4,534
| – | – | ﹤0.01% | 5624 |
|
|
2024
Q2 | $14.1K | Buy |
4,534
+10
| +0.2% | +$31 | ﹤0.01% | 5511 |
|
|
2024
Q1 | $20.5K | Sell |
4,524
-113
| -2% | -$513 | ﹤0.01% | 5313 |
|
|
2023
Q4 | $31.9K | Sell |
4,637
-30
| -0.6% | -$206 | ﹤0.01% | 5189 |
|
|
2023
Q3 | $29.4K | Buy |
4,667
+2,777
| +147% | +$17.5K | ﹤0.01% | 5323 |
|
|
2023
Q2 | $15.7K | Sell |
1,890
-20
| -1% | -$166 | ﹤0.01% | 5691 |
|
|
2023
Q1 | $8.4K | Hold |
1,910
| – | – | ﹤0.01% | 6029 |
|
|
2022
Q4 | $11.3K | Buy |
1,910
+1,689
| +764% | +$9.99K | ﹤0.01% | 5854 |
|
|
2022
Q3 | $2K | Hold |
221
| – | – | ﹤0.01% | 6740 |
|
|
2022
Q2 | $3K | Buy |
221
+88
| +66% | +$1.2K | ﹤0.01% | 6697 |
|
|
2022
Q1 | $5K | Sell |
133
-68
| -34% | -$2.56K | ﹤0.01% | 6421 |
|
|
2021
Q4 | $16K | Buy |
+201
| New | +$16K | ﹤0.01% | 5915 |
|